We are thrilled to launch our new model of Non-Small Cell Lung Cancer. We use patient-derived xenografts as well as mouse allografts to replicate clinical features of this devastating condition. Join us today on our quest for accelerating preclinical drug discovery and combating lung cancer. Explore this and other segment models here: https://ivrs.se/segment-models/
If you have any questions or would like to explore how our expertise can support the next steps in your preclinical pipeline, don’t hesitate to contact us at info@ivrs.se. We look forward to assisting you in advancing lung cancer research and drug development.
